Riversedge Advisors, LLC Astrazeneca PLC Transaction History
Riversedge Advisors, LLC
- $578 Million
- Q3 2025
A detailed history of Riversedge Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Riversedge Advisors, LLC holds 4,880 shares of AZN stock, worth $436,272. This represents 0.06% of its overall portfolio holdings.
Number of Shares
4,880
Previous 4,057
20.29%
Holding current value
$436,272
Previous $283,000
32.16%
% of portfolio
0.06%
Previous 0.06%
Shares
3 transactions
Others Institutions Holding AZN
# of Institutions
1,498Shares Held
500MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...